These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7819617)

  • 1. Mouse antibody-coated lymphocytes during OKT3 therapy in liver transplantation.
    Broughan TA; Valenzuela R; Escorcia E; Secic M; Vogt DP
    Clin Transplant; 1994 Oct; 8(5):488-91. PubMed ID: 7819617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
    Roayaie S; Sheiner PA; Emre S; Guy S; Schwartz ME; Boros P; Miller CM
    Mediators Inflamm; 2000; 9(3-4):141-6. PubMed ID: 11132770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged and repeated courses of OKT3 after liver transplantation.
    Colledan M; Gridelli B; Rossi G; Caccamo L; Gatti S; Bonara P; Fassati LR; Ferla G; Maggi U; Reggiani P
    Transplant Proc; 1990 Aug; 22(4):1769-71. PubMed ID: 2143859
    [No Abstract]   [Full Text] [Related]  

  • 5. OKT3 resistant rejection in liver transplant patients.
    Sutherland F; Lazarovits A; Aboujaoude M; Grant D; Ghent C; Sommerauer J; Wall W
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1413-4. PubMed ID: 1824898
    [No Abstract]   [Full Text] [Related]  

  • 6. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased risk of early rejection correlates with recovery of CD3 cell count after liver transplant in patients receiving OKT3 induction.
    Sheiner PA; Guarrera JV; Grunstein E; Emre S; Guy SR; Schwartz ME; Miller CM; Boros P
    Transplantation; 1997 Oct; 64(8):1214-6. PubMed ID: 9355846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of rabbit antithymocyte serum (RATS) and OKT3 on peripheral blood mononuclear cell subsets following renal transplantation.
    Zaltzman JS; Cole EH; Freedman J
    Clin Transplant; 1994 Dec; 8(6):516-22. PubMed ID: 7865912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated liver allograft rejection during prophylactic immunosuppression with OKT3.
    Sasaki AW; Lee RG; Porayko MK; Benner KG; Hennell KR; Wheeler LJ; Pinson CW
    Transplantation; 1993 Jan; 55(1):216-9. PubMed ID: 8420054
    [No Abstract]   [Full Text] [Related]  

  • 10. CD3 antigen modulation in T-lymphocytes during OKT3 treatment.
    Magnussen K; Klug B; Møller B
    Transplant Proc; 1994 Jun; 26(3):1731. PubMed ID: 8030108
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of different T and B-peripheral blood lymphocyte subsets in liver transplantation after cyclosporine or OKT3 immunosuppressive treatment.
    Minguela A; Alvarez-López MR; Sánchez-Bueno F; Torío A; Muro M; Robles R; Pons JA; Parrilla P; García-Alonso AM
    Transplant Proc; 1995 Aug; 27(4):2317-8. PubMed ID: 7652825
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of the OKT3 first-dose syndrome by reduced initial dose followed by adjusted doses based on CD3 T-lymphocyte counts in pediatric renal graft recipients.
    Piatosa B; Grenda R; Prokurat S
    Transplant Proc; 1996 Dec; 28(6):3466-7. PubMed ID: 8962349
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation.
    Yang J; Ahn C; Jung HK; Kim EK; Kim JY; Kim YS; Han JS; Kim S; Lee JS
    Transpl Immunol; 2003; 11(2):197-206. PubMed ID: 12799204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muromonab-CD3 (Orthoclone OKT3), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation.
    Benekli M; Hahn T; Williams BT; Cooper M; Roy HN; Wallace P; Stewart C; Bambach B; McCarthy PL
    Bone Marrow Transplant; 2006 Sep; 38(5):365-70. PubMed ID: 16862164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
    Alegre ML; Peterson LJ; Xu D; Sattar HA; Jeyarajah DR; Kowalkowski K; Thistlethwaite JR; Zivin RA; Jolliffe L; Bluestone JA
    Transplantation; 1994 Jun; 57(11):1537-43. PubMed ID: 8009586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine monoclonal CD3 antibody (OKT3)-based early rejection prophylaxis in pediatric heart transplantation.
    Shaddy RE; Bullock EA; Morwessel NJ; Hannon DW; Renlund DG; Karwande SV; McGough EC; Hawkins JA
    J Heart Lung Transplant; 1993; 12(3):434-9. PubMed ID: 8329414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of monoclonal antibody OKT3 in solid organ transplantation: a meta-analysis.
    Carrier M; Jenicek M; Pelletier LC
    Transplant Proc; 1992 Dec; 24(6):2586-91. PubMed ID: 1465874
    [No Abstract]   [Full Text] [Related]  

  • 18. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
    Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response against OKT3.
    Chatenoud L
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):68-73. PubMed ID: 8465430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic surveillance of liver transplant patients using monoclonal antibodies against lymphocyte subpopulations].
    Gugenheim J; Canon C; Samuel D; Saliba F; Debotte G; Misset JL; Mathe G; Bismuth H
    Nephrologie; 1987; 8(3):99-101. PubMed ID: 3116444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.